HI
PASG icon

Harbour Investments’s Passage Bio PASG Stock Holding History

Harbour Investments’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24 Hold
3
– – ﹤0.01% 4615
2025
Q4 		$35 Hold
3
– – ﹤0.01% 3805
2025
Q3 		$24 Buy
+3
New +$21 ﹤0.01% 3705
2025
Q2 		– Sell
-3
Closed -$21 – 3692
2025
Q1 		$21 Hold
3
– – ﹤0.01% 3522
2024
Q4 		$34 Hold
3
– – ﹤0.01% 3449
2024
Q3 		$42 Hold
3
– – ﹤0.01% 3351
2024
Q2 		$48 Buy
+3
New +$73 ﹤0.01% 3240

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harbour Investments's PASG Position: Q1 2026 in Review

Harbour Investments held its Passage Bio (PASG) position steady in Q1 2026 at 3 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #4615.

Harbour Investments first reported a position in PASG in Q2 2024 and has held it in 7 quarters since. The position peaked at $48 in Q2 2024. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Harbour Investments held 3 shares of Passage Bio worth $24 as of Q1 2026.
  • Harbour Investments left its Passage Bio share count unchanged in Q1 2026.
  • Passage Bio made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4615 holding.
  • Harbour Investments first reported a position in Passage Bio in Q2 2024 and has held it in 7 quarters since.
  • Harbour Investments's Passage Bio position peaked at $48 in Q2 2024.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.